Sentence examples for commercial marker from inspiring English sources
These data suggest that Mendelian-inheritance error checking is a worthwhile strategy for both types of genotyping data, whereas fine-Mendelian-inheritance errore from checkingnce checkisg than do studies using commercial marker data.
Our previous studies of Y-STR polymorphisms in the South African population identified low levels of diversity and discrimination capacity for many commercial marker sets, determining a limited applicability of these systems to the local population groups.
Inheritance checking of the commercial marker data identified that the results contained 0.13% human errors and 0.12% other errors (0.25% total error), whereas concordance checking found 0.16% human errors.
We identified SNPs that could be included in commercial marker panels for genomic selection or marker-assisted management of feed efficiency traits in Angus cattle (Tables S1– S1).
Next, ILEA sprinting with the unilateral transfemoral amputation was captured by means of a commercial marker-based optical motion capture system with 20 cameras (VICON, Oxford, England) operating at a frame rate of 200 Hz.
An experimental study is undertaken to compare the accuracy of a Kinect with a commercial marker-based motion capture system, VICON, which has been used as the ground truth in prior work (Dutta 2012; Stone and Skubic 2011; Fernández-Baena et al. 2012).
Commercial markers (Seeblue pre-stained standard, Invitrogen) were used as molecular weight standards.
Our data suggest that the commercial markers we are currently relying on to diagnose asthma subtypes are not giving us comprehensive or specific enough information.
Therefore, our data suggest that the commercial markers we are currently relying on to diagnose asthma subtypes are not giving us comprehensive or specific enough information.
SNPs and the commercial SNP marker panels have been successfully used to identify genomic regions that potentially underlie the economic traits of cattle [ 7- 9].
Our three markers are not included in major commercial gene expression marker sets that predict breast tumor recurrence such as MammaPrint (70 markers) or Oncotype DX (16 markers) [ 40, 41], although TGF β receptor II (TGFBR2) was among the initial set of 250 candidate genes considered by Oncotype DX.
